R&D Systems™ Recombinant Cynomolgus/Rhesus Macaque BCMA Fc Protein

Catalog No.	Quantity
10-029-BC050	50 μg

Catalog No. 10-029-BC050 Supplier R&D Systems™ Supplier No. 10029BC050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Cynomolgus/Rhesus Macaque BCMA Fc Protein is derived from HEK293. The Recombinant Cynomolgus/Rhesus Macaque BCMA Fc Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: XP_005591343
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 608
• Molecular Weight (g/mol): 33 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived BCMA/TNFRSF17 protein, (N-terminus) Cynomolgus Monkey BCMA (Met1-Ile54) Accession &Num; XP_005591343 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Gene Alias: B cell maturation antigen, B-cell maturation protein, BCMAtumor necrosis factor receptor superfamily member 17, BCMB-cell maturation factor, CD269, CD269 antigen, TNFRSF13A, TNFRSF17, tumor necrosis factor receptor superfamily, member 17
• Specific Reactivity: BCMA/TNFRSF17
• Conjugate: Unconjugated
• Species: Cynomolgus Monkey, Rhesus macaque
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.